Skip to main content

EVA - patient ventilation beyond limits

Objective

EVA - Expiratory Ventilation Assistance – , or expiration by suction, is an innovative method to mechanically ventilate patients and is a key step in ventilation towards less-invasive, tailored and improved patient care as it enables:
1. full ventilation through a thin catheter instead of a thick tube
2. low and – if needed – negative pressures in the lungs promoting blood circulation
3. controlling the expiration, reducing sheer stress, which may prevent lung injury and improve patient outcome.

The EVA technology has already been on the market for some years in its most basic form: the manual, disposable emergency ventilator Ventrain®. Since market launch in 2011, Ventrain® is now being sold by 16 distributors in over 20 countries.
Ventinova’s flagship is the “EVA device”: a fully automated ventilator based on EVA technology meeting the emerging needs of less invasive, tailored and improved patient care. First is focused on the large markets of elective surgical procedures and emergency care (€ 400 M, globally) and in 2nd generation on ICU-ventilation (€ 500 M, globally), before becoming ‘standard care’ (€ 4.6 billion, globally). The device, currently at TRL6, is still in development and CE marking is expected in Q3 2016. Next to marketing activities, such as organizing workshops and training sessions, and careful selection and support of distributors, penetration of the conservative medical market should be ensured by demonstration of better and tailored patient care using EVA ventilation in pre-clinical studies and controlled clinical trials. These are to be designed and executed in close collaboration with Key Opinion Leaders of established and world leading academic medical centers.

The described technology and products are protected by 5 patent families and design and brand registrations. The products are manufactured in The Netherlands and a dedicated catheter in Ireland. After CE marking, large non-EU markets are to be entered (e.g. USA, China, Russia).

Field of science

  • /medical and health sciences/clinical medicine/pneumology
  • /social sciences/economics and business/business and management/commerce

Call for proposal

H2020-FTIPilot-2015-1
See other projects for this call

Funding Scheme

IA - Innovation action

Coordinator

VENTINOVA MEDICAL BV
Address
Meerenakkerplein 7
5652 BJ Eindhoven
Netherlands
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
EU contribution
€ 793 261,87

Participants (4)

UNIVERSITAETSKLINIKUM FREIBURG
Germany
EU contribution
€ 621 250
Address
Hugstetter Strasse 49
79106 Freiburg
Activity type
Higher or Secondary Education Establishments
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS

Participation ended

France
EU contribution
€ 21 487,50
Address
3 Avenue Victoria
75000 Paris
Activity type
Research Organisations
UNITRON INNOTECH BV
Netherlands
EU contribution
€ 390 999,88
Address
Asveldweg 2
7556 BP Hengelo
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
REGION HOVEDSTADEN
Denmark
EU contribution
€ 63 000,75
Address
Kongens Vaenge 2
3400 Hillerod
Activity type
Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)